However, the inclusion of SOX10 as a screening tool in high-grade unclassified uterine sarcomas could enhance recognition of this entity, especially in putative cases of undifferentiated uterine sarcomas, and could enhance the precision of the diagnosis and treatment strategies [56]. Here, SOX10 is linked to uterine corpus sarcoma.